Previous 10 | Next 10 |
Zimmer Biomet Announces 2024 Investor Day PR Newswire WARSAW, Ind. , May 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it will host an Investor Day on Wednesday, May 29, 20...
(NewsDirect) Regenerative medicine is revolutionizing healthcare. It encompasses a range of cutting-edge therapies aimed at repairing or replacing damaged tissues and organs, offering tangible solutions rather than mere symptom management. With a global market projected to surge from USD 29.4...
2024-05-17 15:19:41 ET Summary Zimmer Biomet Holdings, Inc.'s growth has been modest, as investors are concerned about the rise of GLP-1 drugs, raising concerns about future growth. The company's revenue stagnated after spinning off its dental and spine operations, but recently ha...
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024 PR Newswire WARSAW, Ind. , May 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors ha...
2024-05-07 20:26:14 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
Zimmer Biomet Publishes 2023 Sustainability Report PR Newswire Sustainability report highlights progress in product quality and safety, environmental and greenhouse gas emissions goals, and team member engagement and development WARSAW, Ind. , May 6, 2024 ...
2024-05-02 13:23:08 ET Zimmer Biomet Holdings, Inc. (ZBH) Q1 2024 Earnings Conference Call May 2, 2024, 8:30 AM ET Company Participants Keri Mattox - Chief Communications and Administration Officer Ivan Tornos - President and CEO Suky Upadhyay - Executive Vice Pr...
2024-05-02 06:42:28 ET More on Zimmer Biomet Zimmer Biomet Holdings, Inc. (ZBH) Q4 2023 Earnings Call Transcript Zimmer Biomet: Weight Loss Drug Concerns Are Overblown Zimmer Biomet Q1 2024 Earnings Preview Zimmer Biomet wins FDA clearance for ROSA Shoulder S...
Zimmer Biomet Announces First Quarter 2024 Financial Results PR Newswire First quarter net sales of $1.889 billion increased 3.2% and 4.4% on a constant currency 1 basis First quarter diluted earnings per share were $0.84 ; adjusted 1 diluted earnings per s...
2024-05-01 11:45:13 ET More on Zimmer Biomet Zimmer Biomet Holdings, Inc. (ZBH) Q4 2023 Earnings Call Transcript Zimmer Biomet: Weight Loss Drug Concerns Are Overblown Zimmer Biomet wins FDA clearance for ROSA Shoulder System Zimmer Biomet Q4 2023 Earnings Pr...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
Zimmer Biomet Holdings Inc. Website:
2024-07-15 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results PR Newswire WARSAW, Ind. , July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors PR Newswire WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdika...